What is a “Sequence Listing XML” and when is it required?

A “Sequence Listing XML” is a standardized format for presenting nucleotide and/or amino acid sequences in patent applications. It is required for all applications filed on or after July 1, 2022, that have disclosures of nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b). The XML format ensures that sequence information is machine-readable…

Read More

What is the requirement for submitting a “Sequence Listing XML” in international applications under the PCT?

According to MPEP 2414.05, international applications filed under the PCT that contain a disclosure of nucleotide and/or amino acid sequences must include a sequence listing part of the description that complies with the standard provided in Annex C of the Administrative Instructions. The MPEP states: “Where an international application, filed under the PCT, contains a…

Read More

What statements are required when adding a “Sequence Listing XML” to a patent application?

When adding a “Sequence Listing XML” to a patent application, two important statements are required: A statement indicating the basis for the amendment, with specific references to particular parts of the application as originally filed (specification, claims, drawings) for all sequence data in the “Sequence Listing XML”. A statement that the “Sequence Listing XML” includes…

Read More